Download our app Order a test
News

CTCs can play a key role in improving metastatic breast cancer treatment

Circulating tumour cells (CTCs) can play a crucial role in improving treatments for metastatic breast cancer, scientists have found. The simple blood test can provide clinicians with a reliable predictor of whether a treatment will be successful in less than a month, an audience at the 2020 San Antonio Breast Cancer Symposium heard in December. […]

Read more
News

The future of liquid biopsy

UK scientists have discovered that liquid biopsy tests are 99% accurate at picking up crucial genetic mutations in patients with returning breast cancer. Researchers studying the potential for liquid biopsies have concluded that circulating tumour DNA (ctDNA) testing can provide an accurate genomic profile of advanced cancer, without the need for an invasive and potentially […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more